Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Timing matters when it comes to retirement planning. Learn when you should start planning to maximize your savings and ensure a secure future.
26,056 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A senior AI executive is leaving Meta Platforms, adding to tech worries. On Wednesday, the stock fell more than 5%, p...
A large insider purchase by Conagra's CEO has investors buzzing. Learn what insider buying signals really mean, how t...
A fresh institutional stake in PENN Entertainment signals shifting sentiment in a dynamic gaming landscape. This deep...
Apple’s WWDC highlights mapped onto the stock market today, june. This piece breaks down the AI announcements, the pr...
NVIDIA's leadership and AI-driven demand are reshaping the stock market landscape. This article dives into what Jense...
A revealing look at how the crypto world got swept up in an illusion of money and momentum. Learn what happened, why ...
Rivian's shares fell despite peers seeing price-target bumps as investors weigh the upcoming R2 launch. This guide br...
This year’s Federal Reserve stress tests delivered a standout message: America’s banks are sturdier than ever. All ma...
As energy markets tilt between supply concerns and resilient cash flow, March can be a strategic moment to position f...
A surge in AI workloads hinges on memory, and Micron’s latest signals hint at lasting strength. This piece unpacks wh...
As Ranpak tackles 2025 earnings, investors watch for sustainable packaging demand, margin discipline, and cash flow r...